Poor purity can cause patients to experience fever, chills, nausea, skin irritation, infections and low blood pressure.

WW International, known as WeightWatchers, saw its stock soar on new of its new compounded GLP-1 offering. But analysts say ...

A recently released negative study by Novo Nordisk (NVO) on the differences between its own semaglutide and liraglutide ...

WW stock popped after announcing a new compounded semaglutide product to benefit from the current shortage of weight loss ...

Now that the Mounjaro and Zepbound shortage is over, Eli Lilly is going after the cottage industry selling “compounded” ...

Mounjaro and Zepbound are now out of shortage. This should be good news—but because so many patients are taking compounded ...

With the resolution, compounding pharmacies are no longer able to produce tirzepatide. And the FDA highlighted the point to ...

Some patients fear that they’ll lose access to tirzepatide because the US Food and Drug Administration determined that a ...

The embattled diet brand said it is adding a compounded weight-loss drug in accordance with FDA rules and manufacturing ...

WeightWatchers recently announced the inclusion of compounded semaglutide into its suite of offerings. This new clinical weight management intervention aims to broaden access for eligible members who ...

WeightWatchers (NASDAQ: WW) (“WeightWatchers,” “WW,” or the “Company”) announced today the addition of compounded semaglutide into its offering, broadening eligible members’ access to clinical weight ...